Bristol-Myers Squibb

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments, pharmaceuticals and nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.
Company Growth (employees)
New York, US
Size (employees)
25,000 (est)
Bristol-Myers Squibb was founded in 1887 and is headquartered in New York, US

Key People at Bristol-Myers Squibb

Giovanni Caforio

Giovanni Caforio

Chief Executive Officer
Charles Bancroft

Charles Bancroft

Executive Vice President, CFO
Francis Cuss

Francis Cuss

Executive Vice President and Chief Scientific Officer
Lamberto Andreotti

Lamberto Andreotti

Chairman, Board of Directors

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in New York, Jacksonville, Atlanta, Birmingham and in 164 other locations
New York, US (HQ)
345 Park Avenue
Show all (169)

Bristol-Myers Squibb Data and Metrics

Bristol-Myers Squibb Financial Metrics

Bristol-Myers Squibb's revenue was reported to be $19.4 b in FY, 2016 which is a 17% increase from the previous period.

Revenue (FY, 2016)

19.4 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

14.5 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

4.5 b

Market capitalization (17-Aug-2017)

93.3 b

Cash (31-Dec-2016)

4.2 b


95.8 b
Bristol-Myers Squibb's current market capitalization is $93.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


16.4 b15.9 b16.6 b19.4 b

Revenue growth, %


Cost of goods sold

4.6 b3.9 b3.9 b4.9 b

Gross profit

11.8 b11.9 b12.7 b14.5 b

Gross profit Margin, %


Operating expense total

13.5 b13.5 b14.5 b13.5 b

Pre tax profit

2.9 b2.4 b2.1 b5.9 b

Income tax expense

311 m352 m446 m1.4 b

Net Income

2.6 b2 b1.6 b4.5 b
USDFY, 2013FY, 2014FY, 2015FY, 2016


3.6 b5.6 b2.4 b4.2 b


1.5 b1.6 b1.2 b1.2 b

Current Assets

18.9 b14.6 b10.4 b13.7 b


7.1 b7 b6.9 b6.9 b

Total Assets

38.6 b33.7 b31.7 b33.7 b

Accounts Payable

2.6 b2.5 b1.6 b1.7 b

Dividends Payable

634 m645 m655 m

Total Debt

8.3 b7.8 b6.7 b6.7 b

Current Liabilities

12.4 b8.5 b8 b8.8 b

Retained Earnings

33 b32.5 b31.6 b33.5 b

Total Equity

15.2 b15 b14.4 b16.3 b

Debt to Equity Ratio

0.5 x0.5 x0.5 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.2 x

Financial Leverage

2.5 x2.3 x2.2 x2.1 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.6 b2 b1.6 b4.5 b


(45 m)(254 m)97 m(152 m)

Accounts Payable

412 m(44 m)(919 m)104 m

Cash From Operating Activities

3.5 b3.1 b1.8 b2.9 b

Capital Expenditures

(820 m)(1.2 b)

Cash From Investing Activities

(572 m)1.2 b(1.6 b)1.5 b

Long-term Borrowings

(597 m)(676 m)(2 b)(15 m)

Cash From Financing Activities

(1.1 b)(2.4 b)(3.4 b)(2.4 b)

Free Cash Flow

2.7 b4.1 b
USDY, 2016


33.6 x


23.6 x


777.1 k


0.4 x


0.2 x

Financial Leverage

2.1 x

Bristol-Myers Squibb Operating Metrics

Y, 2015Y, 2016

Phase III Trials


Projects in R&D Pipeline


Bristol-Myers Squibb Market Value History

Bristol-Myers Squibb Median Salaries

Source: 359 public H-1B filings from Bristol-Myers Squibb

Traffic Overview of Bristol-Myers Squibb

Bristol-Myers Squibb Online and Social Media Presence

Bristol-Myers Squibb Company Life and Culture

You may also be interested in